A novel synthetic lethal target for ATM inhibitors in pancreatic cancer

A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic lethal marker for enhancing the efficacy of ATM inhibitors in pancreatic cancer treatment.

Early adversity leads to accelerated brain development with long-term risks

A study led by researchers from A*STAR’s Singapore Institute for Clinical Sciences (SICS) has found evidence suggesting that children exposed to elevated levels of early

January 16, 2024

CSL doses first patient with haemophilia B gene therapy Hemgenix – Pharmaceutical Technology

CSL’s Hemgenix uses an engineered adeno-associated virus (AAV) to make the body produce blood clotting proteins. Source: Shutterstock / Kateryna Kon. CSL announced the first

June 21, 2023

AMA Too Woke? FDA Warns on Probiotics; Medicare Drug-Price Negotiation Moves Forward

Note that some links may require registration or subscription. The GOP’s physician lawmakers in Congress say the American Medical Association’s “wokeism” is straining its credibility

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.